8-K - Bicara Therapeutics Inc. Common Stock | StockGist

Current Report Details

Event Type

Material Agreement

Financial Results

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

. Entry into a Material Definitive Agreement. On February 24, 2026, Bicara Therapeutics Inc. (the “Company”) entered into an underwriting agreement (the “Underw

Material Agreement

$16.00$16.00$161.8M

2.02

is being furnished and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the “Exchange Ac

Financial Results

9.01

Financial Statements and Exhibits. (d) The following exhibits are being filed herewith: Exhibit No. Description 1.1 Underwriting Agreement dated February 24, 20

Exhibits Only

Exhibits (4)

1.1

EX-1.1

4.1

EX-4.1

5.1

EX-5.1

8-K